|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
|
ES2532906T5
(es)
|
2002-10-25 |
2022-03-23 |
Foamix Pharmaceuticals Ltd |
Espuma cosmética y farmacéutica
|
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
|
US20080138296A1
(en)
*
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
|
US7416756B2
(en)
|
2003-09-10 |
2008-08-26 |
Eastman Chemical Company |
Process for the recovery of a phytolipid composition
|
|
US20050239745A1
(en)
*
|
2004-03-03 |
2005-10-27 |
Ophthalmic Research Associates, Inc. |
Novel topical ophthalmic formulations
|
|
BRPI0518829A2
(pt)
|
2004-12-06 |
2008-12-09 |
Avigen Inc |
mÉtodo para o tratamento de dor neuropÁtica e sÍndromes associadas
|
|
TWI462745B
(zh)
*
|
2005-04-28 |
2014-12-01 |
Takeda Pharmaceutical |
安定的乳化組成物
|
|
US8187659B2
(en)
*
|
2006-05-02 |
2012-05-29 |
Jerry Robertson Real Estate Llc |
Solid medicament dosage form consumption aid
|
|
JPWO2007132825A1
(ja)
*
|
2006-05-15 |
2009-09-24 |
武田薬品工業株式会社 |
医薬
|
|
US20070275053A1
(en)
*
|
2006-05-26 |
2007-11-29 |
Luise Anneliese Lenk |
Anti-stick formula delivered by spray process to facilitate swallowing of solid object, such as pill, tablet capsule or caplet.
|
|
JP5193870B2
(ja)
|
2006-09-05 |
2013-05-08 |
キユーピー株式会社 |
プロスタグランジン脂肪乳剤およびその製造方法、ならびにその安定化方法および乳化剤
|
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
|
EP2131841B1
(en)
*
|
2007-01-30 |
2012-08-01 |
Avigen, Inc. |
Methods for treating acute pain
|
|
US20080234376A1
(en)
*
|
2007-03-21 |
2008-09-25 |
Taiwan Liposome Company (A Taiwan Corporation) |
Emulsion composition comprising prostaglandin e1
|
|
US20080287402A1
(en)
*
|
2007-05-03 |
2008-11-20 |
Johnson Kirk W |
Use of a glial attenuator to prevent amplified pain responses caused by glial priming
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
RU2418601C2
(ru)
*
|
2007-10-10 |
2011-05-20 |
Закрытое акционерное общество "Эвалар" |
Средство, обладающее гепатопротекторным, детоксицирующим и регенерирующим действием
|
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
|
WO2009090495A2
(en)
|
2007-12-07 |
2009-07-23 |
Foamix Ltd. |
Oil and liquid silicone foamable carriers and formulations
|
|
US8518376B2
(en)
|
2007-12-07 |
2013-08-27 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
|
CA2712120A1
(en)
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
|
US20120087872A1
(en)
|
2009-04-28 |
2012-04-12 |
Foamix Ltd. |
Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
|
|
WO2011013008A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
CA2769625C
(en)
|
2009-07-29 |
2017-04-11 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
|
WO2011039637A2
(en)
|
2009-10-02 |
2011-04-07 |
Foamix Ltd. |
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
|
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
|
NZ601635A
(en)
|
2010-01-27 |
2013-06-28 |
Takeda Pharmaceutical |
Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
|
|
GB2477590A
(en)
*
|
2010-02-05 |
2011-08-10 |
Biocopea Ltd |
A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
|
|
US10695432B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
|
US9271950B2
(en)
|
2010-10-29 |
2016-03-01 |
Infirst Healthcare Limited |
Compositions for treating chronic inflammation and inflammatory diseases
|
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
|
US10695431B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
|
US9504664B2
(en)
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
US8895536B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating chronic inflammation and inflammatory diseases
|
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
|
US9737500B2
(en)
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
CA2820721C
(en)
*
|
2010-12-10 |
2017-07-11 |
Ns Technologies Pty Ltd |
Methods for forming miniemulsions and use thereof for delivering bioactive agents
|
|
EP3247384B1
(en)
|
2015-01-14 |
2023-10-04 |
The Regents of the University of Colorado, a body corporate |
In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
|
|
WO2016191634A1
(en)
*
|
2015-05-28 |
2016-12-01 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods of preventing and treating autoimmunity
|
|
EP3432877B1
(en)
|
2016-03-24 |
2023-01-11 |
ImmunoMolecular Therapeutics, Inc. |
D-alpha-methyldopa for treating autoimmune disease
|
|
US10398641B2
(en)
|
2016-09-08 |
2019-09-03 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
|
US11052060B2
(en)
|
2018-02-12 |
2021-07-06 |
The Regents Of The University Of Colorado, A Body Corporate |
Compounds and methods for treating autoimmunity
|
|
US11013707B2
(en)
|
2018-03-23 |
2021-05-25 |
The Regents Of The University Of Colorado, A Body Corporate |
Administration of oral methyldopa
|